Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
Akeso Inc. Published 2023 Interim Results Positive Profit Alert 2023-07-31 12:33
NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma 2023-07-31 12:09
HANQUYOU Marks 3rd Anniversary with Brilliant Achievements 2023-07-28 15:27
Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch 2023-07-28 10:00
2023 Tsinghua Amgen Scholars Program Kicks Off 2023-07-27 21:00
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update 2023-07-27 19:00
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients 2023-07-27 08:53
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-07-26 20:00
Samsung Biologics Reports Second Quarter 2023 Financial Results 2023-07-26 15:23
China's Yunhong Group furthers global push on full biodegradation 2023-07-26 13:07
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023 2023-07-26 00:00
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement 2023-07-25 19:30
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial 2023-07-24 21:02
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 2023-07-22 04:30
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND 2023-07-22 00:00
SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979 2023-07-21 22:51
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent 2023-07-21 16:47
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer 2023-07-21 08:15
Angel Yeast Highlights Sustainable Protein and Natural Taste Solutions at IFT FIRST 2023 2023-07-20 20:00
1 45 46 47 48 49 222